๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐๐๐ฐ๐๐จ๐ซ๐ง ๐๐๐ซ๐๐๐ง๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐, ๐๐ก๐๐ซ๐ & ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐๐๐-๐๐๐๐)
๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐- https://lnkd.in/dgM4Yq8y
The North America newborn screening market is witnessing robust growth, with revenue increasing from 980 Million USD in 2020 to 1,370 Million USD in 2025, ultimately projected to reach 2,230 Million USD by 2035. This growth trajectory is attributed to increased test volumes, expanding screening panels, and greater public health investments. The upward trend underscores the region's commitment to improving neonatal health outcomes through early and comprehensive diagnostic programs, further supported by rapid technological innovation.
Key Drivers
Rising prevalence of congenital disorders and mandatory government regulations across the US and Canada are driving hospitals and laboratories to boost screening volumes. In 2024, PerkinElmer Inc. expanded its reagent kit offerings to meet regulatory inclusions for Cystic Fibrosis and Sickle Cell Disease screening.
Key Trends
Adoption of multiplex testing technologies is accelerating, allowing simultaneous screening for multiple metabolic and genetic disorders. Bio-Rad Laboratories Inc. introduced a multi-analyte panel in 2024 to streamline workflows and reduce sample-to-answer time for clinics.
Expansion of point-of-care screening, including pulse oximetry and portable hearing tests, is enhancing coverage in rural and community settings. Masimo Corporation announced a new generation of pulse oximeters in June 2024, optimized for neonatal accuracy.
Market Insights & Segmentation
Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types),
Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications),
Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels),
Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies),
Organization Size (Small, Medium, Large)
Key Market Companies
PerkinElmer Inc.,Natus Medical Incorporated,Bio-Rad Laboratories Inc.,Trivitron Healthcare,Masimo Corporation,Medtronic Plc,Thermo Fisher Scientific Inc.,Baebies Inc.,Demant A/S,Centogene N.V.,BioVision Technologies,Agilent Technologies Inc.,BioTek Instruments Inc.,AB Sciex,MedScreen Inc.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ- https://lnkd.in/dQArJyYY
๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐- https://lnkd.in/dgM4Yq8y
The North America newborn screening market is witnessing robust growth, with revenue increasing from 980 Million USD in 2020 to 1,370 Million USD in 2025, ultimately projected to reach 2,230 Million USD by 2035. This growth trajectory is attributed to increased test volumes, expanding screening panels, and greater public health investments. The upward trend underscores the region's commitment to improving neonatal health outcomes through early and comprehensive diagnostic programs, further supported by rapid technological innovation.
Key Drivers
Rising prevalence of congenital disorders and mandatory government regulations across the US and Canada are driving hospitals and laboratories to boost screening volumes. In 2024, PerkinElmer Inc. expanded its reagent kit offerings to meet regulatory inclusions for Cystic Fibrosis and Sickle Cell Disease screening.
Key Trends
Adoption of multiplex testing technologies is accelerating, allowing simultaneous screening for multiple metabolic and genetic disorders. Bio-Rad Laboratories Inc. introduced a multi-analyte panel in 2024 to streamline workflows and reduce sample-to-answer time for clinics.
Expansion of point-of-care screening, including pulse oximetry and portable hearing tests, is enhancing coverage in rural and community settings. Masimo Corporation announced a new generation of pulse oximeters in June 2024, optimized for neonatal accuracy.
Market Insights & Segmentation
Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types),
Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications),
Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels),
Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies),
Organization Size (Small, Medium, Large)
Key Market Companies
PerkinElmer Inc.,Natus Medical Incorporated,Bio-Rad Laboratories Inc.,Trivitron Healthcare,Masimo Corporation,Medtronic Plc,Thermo Fisher Scientific Inc.,Baebies Inc.,Demant A/S,Centogene N.V.,BioVision Technologies,Agilent Technologies Inc.,BioTek Instruments Inc.,AB Sciex,MedScreen Inc.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ- https://lnkd.in/dQArJyYY
209 Views
